pregleda

VALPROATE- Michael Parnham


Cena:
8.000 din
Želi ovaj predmet: 1
Stanje: Polovan bez oštećenja
Garancija: Ne
Isporuka: Pošta
Post Express
Lično preuzimanje
Plaćanje: Tekući račun (pre slanja)
Pouzećem
Lično
Grad: Beograd-Kumodraž,
Beograd-Voždovac
Prodavac

DucaR81 (1135)

100% pozitivnih ocena

Pozitivne: 7806

  Pošalji poruku

Svi predmeti člana


Kupindo zaštita

Oblast: Ostalo
Godina izdanja: 1999
ISBN: 3-7643-5836-X
Jezik: Engleski
Autor: Strani

Tvrd povez,
281 strana,
1999 godina
Izdavac: Birkhauser Verlag, Basel, Boston, Berlin

Knjiga lepo ocuvana

P2/3

In this book, emphasis is placed on the scientific background leading to the discovery of valproate, and its clinical development into one of the most widely used antiepileptic drugs, a milestone in drug therapy. It reviews the state of the drug, and looks at hypotheses on its mechanisms of action, its metabolism into pharmacologically active metabolites, its unique distribution characteristics, and its various clinical uses

Valproic acid was first synthesized in 1882 by Burton, but there was no known clinical use until its anticonvulsant activity was fortuitously discovered by H. Meunier in 1963 in the laboratory of G. Carraz. The first clinical trials of the sodium salt of valproate were reported in 1964 by Carraz. It was marketed in France in 1967 and was released in the United States in 1978 for the treatment of epilepsy. Since then, valproate has established itself worldwide as a major antiepileptic drug against several types of seizures. Clinical experience with valproate has continued to grow in recent years, including use of valproate for diseases other than epilepsy, for example in bipolar disorders and migraine. In this book, emphasis is placed on the scientific background leading to the discovery of valproate and its clinical development into one of the most widely and successfully used antiepileptic drugs, a real milestone in drug therapy. The current state of knowledge of valproate is reviewed by experts in the field, including new hypotheses on its mechanisms of action, its metabolism into pharmacologically active metabolites, its unique distribution characteristics, its undesirable hepatotoxic and teratogenic adverse effects, and its various clinical uses. The monograph is aimed at a broad readership, particularly neurologists, psychiatrists and basic scientists working in the field of epilepsy research. Furthermore, the book also deals with structure-activity relationships of valproate as well as of its metabolites and analogs and should therefore attract researchers working in medicinal chemistry.

- Ne šaljem robu van Srbije
- Lično preuzimanje važi za Beograd, kod Farmaceutskog fakulteta
- Ne saljem knjige na Kosovo

Predmet: 69243573
Tvrd povez,
281 strana,
1999 godina
Izdavac: Birkhauser Verlag, Basel, Boston, Berlin

Knjiga lepo ocuvana

P2/3

In this book, emphasis is placed on the scientific background leading to the discovery of valproate, and its clinical development into one of the most widely used antiepileptic drugs, a milestone in drug therapy. It reviews the state of the drug, and looks at hypotheses on its mechanisms of action, its metabolism into pharmacologically active metabolites, its unique distribution characteristics, and its various clinical uses

Valproic acid was first synthesized in 1882 by Burton, but there was no known clinical use until its anticonvulsant activity was fortuitously discovered by H. Meunier in 1963 in the laboratory of G. Carraz. The first clinical trials of the sodium salt of valproate were reported in 1964 by Carraz. It was marketed in France in 1967 and was released in the United States in 1978 for the treatment of epilepsy. Since then, valproate has established itself worldwide as a major antiepileptic drug against several types of seizures. Clinical experience with valproate has continued to grow in recent years, including use of valproate for diseases other than epilepsy, for example in bipolar disorders and migraine. In this book, emphasis is placed on the scientific background leading to the discovery of valproate and its clinical development into one of the most widely and successfully used antiepileptic drugs, a real milestone in drug therapy. The current state of knowledge of valproate is reviewed by experts in the field, including new hypotheses on its mechanisms of action, its metabolism into pharmacologically active metabolites, its unique distribution characteristics, its undesirable hepatotoxic and teratogenic adverse effects, and its various clinical uses. The monograph is aimed at a broad readership, particularly neurologists, psychiatrists and basic scientists working in the field of epilepsy research. Furthermore, the book also deals with structure-activity relationships of valproate as well as of its metabolites and analogs and should therefore attract researchers working in medicinal chemistry.
69243573 VALPROATE- Michael Parnham

LimundoGrad koristi kolačiće u statističke i marketinške svrhe. Nastavkom korišćenja sajta smatramo da ste pristali na upotrebu kolačića. Više informacija.